Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-101.38M -94.7M -86.92M -83.22M -80.69M -78.65M -76.41M -70.84M -68.22M -63.39M -58.76M -53.84M -46.77M -42.16M -35.25M -28.52M -23.32M -20.62M
Depreciation & Amortization
1.18M 1.21M 1.22M 1.26M 1.29M 1.27M 1.29M 1.29M 1.25M 1.25M 1.18M 1.08M 998K 902K 831K 827K 843K 834K
Stock-Based Compensation
13.03M 12.33M 11.72M 11.39M 10.96M 9.77M 8.77M 7.98M 7.38M 6.73M 6.41M 5.89M 4.73M 3.72M 2.31M 1.19M 826K 744K
Other Working Capital
1.44M 3.7M -3.12M -295K -3.06M -2.93M 5.78M -589K 2.11M 1.63M -3.75M -1.12M -3.6M -4.59M -1.37M 1.42M 970K -627K
Other Non-Cash Items
1.05M -2.03M 309K 3.29M 4.42M 5.93M 2.69M 297K -497K -1.05M -122K -24.39M -24.05M -24.05M -24.09M 1K n/a 589K
Deferred Income Tax
n/a n/a n/a -2.79M -3.61M -4.64M -4.64M -1.85M -1.03M n/a n/a 24.11M 24.06M 24.11M 24.11M -4K 48K -4K
Change in Working Capital
2.44M 4.16M -2.64M 334K -2.24M -2.07M 4.44M -1.36M 1.29M 853K -3.1M -1.33M -5.36M -4.99M -315K 2.43M -403K -2.91M
Operating Cash Flow
-83.35M -78.71M -79.81M -73.24M -73.37M -71.89M -63.85M -64.47M -59.83M -55.81M -54.6M -48.67M -46.6M -42.47M -32.41M -24.08M -22M -21.37M
Capital Expenditures
-866K -1.35M -1.25M -1.27M -1.02M -688K -709K -750K -723K -604K -1.09M -1.55M -2.06M -2.65M -2.13M -1.44M -966K -364K
Cash Acquisitions
n/a n/a n/a 89.8K 89.8K 89.8K 156.57K 83.29K 83.29K 83.29K 16.52K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-29.99M -29.91M -59.11M -203.91M -183.91M -174M -233.65M -137.37M -137.37M -183.73M -119.78M -71.27M -71.27M -24.9M n/a n/a n/a n/a
Sales Maturities Of Investments
120.23M 120.5M 129.18M 154.18M 145.68M 137M 120.4M 97.4M 93.69M 75.09M 53.01M 21.01M 3M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 9.48M 9.39M 9.42M 9.44M -113.25K -39.97K -43.68K -43.43M -68.26M -68.25M -68.27M -24.9M n/a n/a n/a n/a
Investing Cash Flow
89.37M 89.24M 68.82M -50.99M -39.25M -37.69M -113.96M -40.72M -44.4M -109.25M -67.87M -51.81M -70.33M -27.55M -2.13M -1.44M -966K -364K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
71.28M 1.44M 1.59M 94.04M 93.59M 95.99M 95.94M 11.5M 11.33M 9.16M 8.98M 80.57M 79.35M 78.79M 79.03M -1.04M 25K 366K
Financial Cash Flow
71.28M 1.44M 1.59M 94.04M 94.95M 97.34M 97.29M 99.5M 97.98M 95.81M 95.63M 80.57M 79.35M 78.79M 166.26M 91.25M 97.17M 97.51M
Net Cash Flow
77.29M 11.95M -9.39M -30.2M -17.68M -12.23M -80.52M -5.69M -6.25M -69.25M -26.84M -19.91M -37.58M 8.76M 131.72M 65.73M 74.2M 75.77M
Free Cash Flow
-84.22M -80.06M -81.06M -74.51M -74.39M -72.58M -64.56M -65.22M -60.55M -56.42M -55.7M -50.23M -48.67M -45.13M -34.53M -25.52M -22.97M -21.73M